EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Doxorubicin Toxicity and Recent Approaches to Alleviating Its Adverse Effects with Focus on Oxidative Stress

Lyubomira Radeva iD, Krassimira Yoncheva iD

Molecules · 07.08.2025 · 30 (15) · 3311

DOI: 10.3390/molecules30153311 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 07.08.2025. Verfasst von Lyubomira Radeva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Oxidative Stress, Doxorubicin, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Sofia, Council of Medical Science, Medical University of Sofia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the significant antitumor potential of doxorubicin and its widespread use in the treatment of various oncological diseases, its application is associated with side effects, among which the most common are cardiotoxicity, hepatotoxicity, nephrotoxicity, neurotoxicity, and gonadotoxicity. In contemporary times, innovative strategies to overcome the toxicity of doxorubicin and improve the effectiveness of therapies are intensively researched. The aim of this review is to discuss different approaches to alleviate the common toxic effects of doxorubicin, with an emphasis on oxidative stress. In particular, the review analyzes the significance of pharmaceutical nanotechnology for reducing doxorubicin toxicity while maintaining its antitumor effect (e.g., encapsulation of doxorubicin in passively and/or actively targeted nanoparticles to tumor tissue and cells). Other strategies commented in the review are the simultaneous delivery of doxorubicin with antioxidants and the administration of its derivatives with lower toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressDoxorubicinAntibiotics, AntineoplasticHumansAnimalsAntioxidantsCardiotoxicityNanoparticlesNeoplasms

Stichwörter der Autor:innen

antioxidantsco-administrationdoxorubicinencapsulationnanoparticlestoxicity

Substanzen

DoxorubicinAntioxidantsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.

ORCID-Profile: Lyubomira Radeva, Krassimira Yoncheva

Förderung

  • Medical University of Sofia, Council of Medical Science
  • Medical University of Sofia

Zitieren

APA

Radeva, L., & Yoncheva, K. (2025). Doxorubicin Toxicity and Recent Approaches to Alleviating Its Adverse Effects with Focus on Oxidative Stress. Molecules, 30(15), 3311. https://doi.org/10.3390/molecules30153311

Vancouver

Radeva L, Yoncheva K. Doxorubicin Toxicity and Recent Approaches to Alleviating Its Adverse Effects with Focus on Oxidative Stress. Molecules. 2025;30(15):3311. doi:10.3390/molecules30153311

BibTeX
@article{Radeva2025,
  author = {Radeva, Lyubomira and Yoncheva, Krassimira},
  title = {Doxorubicin Toxicity and Recent Approaches to Alleviating Its Adverse Effects with Focus on Oxidative Stress},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {15},
  pages = {3311},
  doi = {10.3390/molecules30153311}
}
Kostenlos starten →